Ares Acquisition Corporation (NYSE:AAC) announced in an 8-K this morning that it has added up to $60 million in new commitments to its combination with nuclear technology firm X-Energy while further dropping the target’s valuation.
The new money comes in the form of a $30 million increase to the preferred PIPE, which boosts the SPAC’s sponsor total equity investment in the transaction to $80 million, and a commitment to invest up to $30 million from X-Energy founder Kam Ghaffarian.
Together with the other existing funding mechanisms, this deal is now expect to provide up to $534 million in gross proceeds to the target, assuming no redemptions. This would also represent more than half of the company’s equity, under the re-struck terms.
Along with the announcement of the new funding, Ares noted that it has slashed X-Energy’s valuation a second time to $1.05 billion from $1.8 billion under a previous amendment and $2.1 billion at announcement.
The parties initially announced the deal in December 2022 and its post-close enterprise value is now expected to be $1.18 billion according to a refreshed presentation.
Rockville, Maryland-based X-energy has developed small modular nuclear reactor technology designed to provide nuclear plants for projects ranging from individual industrial sites to regional utilities.
Athena Consumer Acquisition Corp. (NYSE:ACAQ) announced this afternoon that its stockholders approved its combination with German EV-maker e.GO at a special meeting held earlier today. Additionally, Athena Consumer’s warrant proposal to convert all outstanding warrants to 0.175 shares in the combined company was also approved. A total of 884,880 shares of Athena Class A Common...
October is set to be a quiet month for lock-up expirations with only four de-SPACs and four sponsors now open to trade their shares for the first time. The first customer is Bitdeer Technologies. Its shareholders and the Blue Safari sponsor both stand to gain the most out of this group from moving some of...
Graf Acquisition Corp. IV (NYSE:GFOR) announced in an 8-K this afternoon that its shareholders approved its combination with NKGen Biotech at a special meeting September 25. A total of 3,386,528 shares were redeemed in connection with the vote, leaving Graf IV with about $27.6 million in the tank and a final redemption rate of 84.3%....
Anzu Special Acquisition Corp I (NASDAQ:ANZU) has closed its combination with Envoy Medical and its shares and warrants are to begin trading on the Nasdaq under the symbols “COCH” and “COCHW” on October 2. The SPAC secured shareholder approval on September 27 and still has not divulged redemption figures. But, it went into the vote...
Mercato Partners (NASDAQ:MPRA) closed its combination with Brazilian software firm Nuvini this afternoon and its shares and warrants are expected to begin trading on the Nasdaq under the symbols “NVNI” and “NVNIW” on October 2. The combined company will continue to be led by its existing CEO and a seven-member Board including Mercato CEO Dr....